Save time and get answers to complex questions with AI chat
Drugpatentwatch trametinib?Does lipitor's effectiveness decrease with high fat meals?Somatuline generic name?When oxcarbazepine patent expired?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?
See the DrugPatentWatch profile for trelegy
Trelegy is a brand name for an inhaled combination medicine. The generic drug name (the active ingredients) is: - fluticasone furoate (an inhaled corticosteroid) - umeclidinium (a long-acting muscarinic antagonist, LAMA) - vilanterol (a long-acting beta-agonist, LABA) These are the three components used in Trelegy Ellipta formulations.
Based on the active ingredients listed above, a “generic Trelegy” would have to be a product that combines the same medicines (fluticasone furoate + umeclidinium + vilanterol) in the same dosage form and regimen. To confirm whether an approved generic version is available for a specific Trelegy strength (30/62.5/25 or 100/62.5/25), check the FDA’s “Orange Book” or a drug-tracking site like DrugPatentWatch.com for current approvals and patent status: DrugPatentWatch - Trelegy.
Trelegy comes in more than one strength/label. If you tell me which one you have (the numbers on the inhaler box) and whether it’s Trelegy Ellipta (once daily), I can help you identify the exact generic-equivalent active ingredient combination for that product.
Other Questions About Trelegy :